Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Eichelbaum

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
British Journal of Clinical Pharmacology|May 21, 2003
Progress in clinical pharmacology over the last 20 yearsMichel Eichelbaum
Pharmacogenetics|June 5, 2003
In search of endogenous CYP2D6 substratesMichel Eichelbaum
Annual Review of Pharmacology and Toxicology|October 3, 2002
Genetic polymorphisms of the human MDR1 drug transporterMatthias Schwab, Michel Eichelbaum, Martin F Fromm
Therapeutic Drug Monitoring|July 2, 2004
Clinical aspects of the MDR1 (ABCB1) gene polymorphismMichel Eichelbaum, Martin F Fromm, Matthias Schwab
European Journal of Clinical Pharmacology|March 1, 2018
Clinical pharmacology in Stockholm 50 years-report from the jubilee symposiumMichel Eichelbaum, Marja-Liisa Dahl, Folke Sjöqvist
Nuclear Receptor|March 27, 2004
Alternative splicing affects the function and tissue-specific expression of the human constitutive androstane receptorKatja A Arnold, Michel Eichelbaum, Oliver Burk
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 18, 2003
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistryUlrich M Zanger, Sebastian Raimundo, Michel Eichelbaum
Annual Review of Medicine|January 18, 2006
Pharmacogenomics and individualized drug therapyMichel Eichelbaum, Magnus Ingelman-Sundberg, William E Evans
Biochemical Pharmacology|January 18, 2005
Inhibition of human CYP2B6 by N,N',N''-triethylenethiophosphoramide is irreversible and mechanism-basedTanja Richter, Matthias Schwab, Michel Eichelbaum, et al.
Genetic Testing|July 30, 2003
Mutational analysis of the human dihydropyrimidine dehydrogenase gene by denaturing high-performance liquid chromatographyJoachim Fischer, Matthias Schwab, Michel Eichelbaum, et al.
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
British Journal of Clinical Pharmacology|May 21, 2003
Progress in clinical pharmacology over the last 20 yearsMichel Eichelbaum
Pharmacogenetics|June 5, 2003
In search of endogenous CYP2D6 substratesMichel Eichelbaum
Annual Review of Pharmacology and Toxicology|October 3, 2002
Genetic polymorphisms of the human MDR1 drug transporterMatthias Schwab, Michel Eichelbaum, Martin F Fromm
Therapeutic Drug Monitoring|July 2, 2004
Clinical aspects of the MDR1 (ABCB1) gene polymorphismMichel Eichelbaum, Martin F Fromm, Matthias Schwab
European Journal of Clinical Pharmacology|March 1, 2018
Clinical pharmacology in Stockholm 50 years-report from the jubilee symposiumMichel Eichelbaum, Marja-Liisa Dahl, Folke Sjöqvist
Nuclear Receptor|March 27, 2004
Alternative splicing affects the function and tissue-specific expression of the human constitutive androstane receptorKatja A Arnold, Michel Eichelbaum, Oliver Burk
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 18, 2003
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistryUlrich M Zanger, Sebastian Raimundo, Michel Eichelbaum
Annual Review of Medicine|January 18, 2006
Pharmacogenomics and individualized drug therapyMichel Eichelbaum, Magnus Ingelman-Sundberg, William E Evans
Biochemical Pharmacology|January 18, 2005
Inhibition of human CYP2B6 by N,N',N''-triethylenethiophosphoramide is irreversible and mechanism-basedTanja Richter, Matthias Schwab, Michel Eichelbaum, et al.
Genetic Testing|July 30, 2003
Mutational analysis of the human dihydropyrimidine dehydrogenase gene by denaturing high-performance liquid chromatographyJoachim Fischer, Matthias Schwab, Michel Eichelbaum, et al.
Pageof 11